OrbiMed
Peter Thompson is currently the CEO and Co-Founder of Terremoto Biosciences, as well as the Co-Founder and Chairman of Silverback Therapeutics. Peter also holds various roles in other companies such as Edgewise Therapeutics and Corvus Pharmaceuticals. With a background in medicine and molecular biology, Peter serves as an Affiliate Professor in Neurosurgery at the University of Washington. Thompson previously held positions at companies like Principia Biopharma and Trubion Pharmaceuticals.
This person is not in any offices
OrbiMed
1 followers
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.